The current evidence base primarily from animal studies and limited human trials suggests the following potential applications: Improved sleep quality increased proportion of slow-wave sleep, reduced sleep latency, fewer nocturnal cortisol spikes Cortisol normalisation reduced HPA hyperactivation, particularly relevant in high-stress or metabolically burdened patients Nociceptive effects several studies indicate DSIP modulates pain processing, with implications for patients whose poor sleep is pain-driven (3) Antioxidant activity may reduce oxidative stress markers, which are elevated in both sleep-deprived and insulin-resistant individuals Neuroendocrine support preliminary evidence of effects on LH, FSH, and somatostatin hormones that regulate testosterone, oestrogen, and growth hormone release Potential stress adaptation some data suggest DSIP may reduce the physiological stress response magnitude without blunting alertness It is important to be precise here

Best for: GLP-1 users who want an easy daily routine, people strength training, anyone who struggles to hit protein consistently
For patients with Long COVID, ME/CFS, or Mast Cell Activation Syndrome (MCAS), the nervous and immune systems are often highly reactive and easily overwhelmed
A pediatric endocrinologist or obesity medicine specialist should evaluate whether GLP-1 therapy is appropriate given the teen's specific health profile, degree of obesity, presence of weight-related complications, and prior treatment attempts
REGAIN: a randomized controlled clinical trial of oxaloacetate for improving the symptoms of long COVID
Vegans or vegetarians are more likely to have a B12 deficiency